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Abstract.  The mitogen-activated  protein  (MAP) ki- 
nase  signal transduction  pathway represents  an impor- 
tant mechanism by which growth factors regulate cell 
function.  Targets  of the MAP kinase pathway are lo- 
cated within several cellular compartments.  Signal 
transduction  therefore requires  the localization  of 
MAP kinase  in each sub-cellular  compartment  that 
contains  physiologically  relevant substrates.  Here,  we 
show that  serum treatment  causes the translocation  of 
two human  MAP kinase  isoforms,  p40  "~k and p41 inapt, 
from the cytosol into the nucleus.  In addition,  we re- 
port that p41 m~k (but not p40  "~'k) is localized at the 
cell surface ruffling membrane in serum-treated  cells. 
To investigate  whether the protein kinase activity of 
MAP kinase  is required  for serum-induced  redistribu- 
tion within the cell,  we constructed  mutated kinase- 
negative forms of p40  ~pk and p41~.  The kinase- 
negative MAP kinases were not observed to localize 
to the cell surface ruffling membrane.  In contrast,  the 
kinase-negative  MAP kinases were observed to be 
translocated  to the nucleus.  Intrinsic  MAP kinase ac- 
tivity is therefore required  only for localization  at the 
cell surface and is not required  for transport  into the 
nucleus. 
Together,  these data demonstrate  that the pattern  of 
serum-induced  redistribution  of p40"~ is different 
from p41,,~k.  Thus,  in addition to common targets of 
signal transduction,  it is possible that these MAP ki- 
nase isoforms may differentially regulate targets lo- 
cated in distinct  sub-cellular compartments. 
C 
ELLULAR proliferation and differentiation is regulated 
by the action of growth factors that bind to specific 
receptors expressed at the surface of responsive cells. 
Growth factor binding to these receptors initiates multiple 
signal  transduction  pathways  that  control  cell physiology. 
One  mechanism  of signal  transduction  by  growth  factor 
receptors  is  represented  by the  mitogen-activated  protein 
(MAP) ~  kinase pathway (2,  15, 19, 46). In the case of signal 
transduction by the EGF receptor it has been demonstrated 
that this pathway is complex and consists of multiple steps 
including the adaptor protein (GRB2/SEM-5 (38, 45), a gua- 
nine nucleotide exchange protein (41), Ras (36, 55, 58), and 
a protein kinase cascade involving a MAP kinase kinase ki- 
nase (c-Raf-1  [21, 32, 34], c-Mos [47], Ste11 [35], or other 
protein kinase [26, 40]), MAP kinase kinase (5,  18, 33, 50, 
56, 59), and MAP kinase (2,  15,  19, 46). 
Growth factor-activated MAP kinase phosphorylates sub- 
strate proteins in vivo. These substrates represent targets of 
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the MAP kinase signal transduction pathway (19).  In vitro 
analysis has demonstrated that MAP kinase exhibits a  re- 
stricted substrate specificity (3,  14,  19, 27). However, sev- 
eral MAP kinase substrates have been identified (19). These 
substrates include: (a) cell surface proteins such as the EGF 
receptor  (44,  53)  and phospholipase  A2 (37,  43);  (b) the 
cytoskeletal proteins tau (22) and caldesmon (12);  and (c) 
the nuclear proteins c-Jun (3, 13, 48), c-Myc (3, 51, 52), NF- 
IL6 (42),  ATF-2 (1), TA/_J (11), and p62rCr/Elk-1 (25, 39). 
The targets of the MAP kinase signal transduction pathway 
are therefore located in the nucleus, the cytoplasm and at the 
cell surface. Analysis of sub-cellular distribution has demon- 
strated the presence of MAP kinase within the cytoplasm and 
the nucleus, but not at the cell surface (3, 10, 49, 52). A fun- 
damental question about the process of signal transduction 
is therefore the identity of the mechanism that allows MAP 
kinase to couple to targets localized at the cell surface and 
within different cellular compartments. 
The  purpose  of this  study  was  to  investigate  the  sub- 
cellular  localization  of the  MAP  kinase  isoforms  p40~pk 
and t>41  m~pk. We report that these MAP kinases are located 
in the cytosol of serum-starved cells. However, serum treat- 
ment causes translocation  of these MAP kinases from the 
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~)  was  also  observed  to be  translocated  to  the  cell 
surface  ruffling  membrane.  The  difference  between  the 
serum-induced redistribution  of p4~  and p41 ~  suggests 
that these MAP kinase isoforms may be coupled to distinct 
targets of signal transduction  in addition to common signal- 
ing pathways. 
Materials and Methods 
Plasmids 
The plasmids pCH110 and pUC13 were from Pharmacia-LKB Biotechnol- 
ogy Inc.  (Piscataway,  NJ).  The plasmid pGEM-Luc was  from Promega 
(Madison, WI). The plasmids pGAIA/Myc and pG5ElbLuc have been de- 
scribed previously  (3, 52).  The plasmid pMyc contains the human c-myc 
gene under the control of an SV-40 promoter (30). The plasmid pG5ElbLuc 
has been described previously  (52). 
The plasmid pCMV-p41 "~  was constructed using a  1,992-bp Espl re- 
striction fragment of the human p41 ''a~ cDNA (28) (available from Gen- 
Bank under accession number Zl1694) cloned as a blunt-ended fragment 
in the SmaI site of the polylinker of the expression vector pCMV5 (4). The 
protein sequence of human IMI  ma~ has a calculated molecular mass of 41 
kD and is 98.3% identical to the rat ERK2 protein kinase (7, 28). Mutation 
of p41  mapk at the ATP binding site to inhibit protein kinase activity was 
performed by replacing  Lys  ~  and Lys  55  (sequence AAGAAA)  in sub- 
region II (according to the nomenclature of Hanks et al. [31]) with two Ala 
residues (sequence GC~)  using a polymerase chain reaction-based 
procedure (54) to create the plasmid pCMV-1Ml(AIa~AIa55)  m~. 
The  plasmid  pCMV-p4(F~  was  constructed  using  a  1,940-bp 
SacII-EspI restriction fragment of the human p40  m~ eDNA (28) (avail- 
able from GenBank under accession number Zl1695) cloned as a blunt- 
ended fragment in the Smal site of the polylinker of the expression vector 
pCMV5. The protein sequence of human p40  ma~ has a calculated molecu- 
lar mass of 40 kD and is 96.8% identical to the rat ERK2 protein kinase 
(7, 28).  Mutation of ~  at the ATP binding site to inhibit protein ki- 
nase  activity  was  performed  by  replacing  Lys  42  and  Lys  43  (sequence 
AAGAAA) in sub-region II with Ala residues (sequence GCGGCA) using 
a polymerase chain reaction-based procedure (54) to create the plasmid 
pCMV-p40(AIa42Ala43)-~  'k. 
Cell Culture and Transfection Assays 
COS-7  cells  were  subcultured  in  DME  supplemented  with  5%  FBS 
(GIBCO BRL, Gaithersburg, MD). Transfections were performed using the 
DEAE-Dextran method as previously  described (3).  The cells were tryp- 
sinized 20 h after transfection,  seeded into 100-ram dishes or 4-well tissue 
culture chambers mounted on a glass slide (Lab-tek, Naperville, IL), and 
incubated in DME containing 5% FBS for 28 h. Serum-starved cells were 
transferred to medium without serum during the last 18 h of incubation. Se- 
rum stimulation was performed by adding DME containing 10% FBS. 
Measurement of  Myc-directed Transactivation of 
Reporter Gene Expression 
Transactivation assays were performed using 0.02/zg of pGAL4/Myc activa- 
tor plasmid and 2/~g ofa lucfferase reporter plasmid (pG5EIBLuc) as previ- 
ously described (51).  Normalization of transfection efficiency  was  per- 
formed  using  a  control  plasmid  (1  tzg  of  pCHll0)  that  expresses 
~-galactosidase.  To investigate the effect of MAP kinase expression, the 
cells were  transfected  with 2  /~g of pCMV5  (vector control),  pCMV- 
p40m~, pCMV-p40(Ala42Ala43)  ~'t, pCMV-p41 '~t, or pCMV-p41(Ala 54 
AlaS5)  "~k. The total DNA in all transfections  was maintained at 10 ~g 
using pUC13 as carrier DNA. The cells were harvested 48 h after transfec- 
tion and cell extracts were prepared as previously described (51). Luciferase 
activity was measured using 2.5/~1 of the cell extract with a luminometer 
(model 2010; Analytical Luminescence Laboratory,  San Diego, CA) (51). 
/3-Galactosidase activity was measured by mixing 15/zl of the cell extract 
with 3  izl of 0.1  M  MgC12/4.5M /3-mercaptoethanol,  66 /~1 of 4  mg/ml 
o-nitrophenyl-/3-o-galactopyranoside  (Sigma Immunoehemicals,  St. Louis, 
MO) and 216 tA of 0.1 M sodium phosphate, pH 7.5. The incubations were 
performed at 37°C for 5 rain or until a faint yellow color appeared.  The 
reactions were stopped by adding 500/~1 of 1 M Na2CO3 to each tube and 
the optical density at 420 um was measured using a  spectrophotometer 
(Pharmacia-LKB  Biotechnology  Inc.). 
Isolation of  Protein Kinases 
The protein kinases p40  s~  and IM1  "~'~ were  isolated from transfected 
COS-7  cells  by  sequential  chromatography  on  Mono-Q  and  phenyl- 
Superose columns (Pharmacia-LKB Biotechnology,  Inc.) as described pre- 
viously (44). 
MAP Kinase Assays 
Protein kinase activity was measured using a synthetic peptide substrate 
based on the sequence  of the EGF receptor surrounding the ~  phos- 
phorylation site 06, 44, 53) as described by Gonzalez et al. (27).  Trans- 
fected  COS-7  cells were lysed  at 4°C in 25 mM Hepes,  pH 7.4,  5 mM 
EDTA, 50 mM NaF, 100/zM sodium orthovanadate,  1 mM PMSF and 10 
/~g/ml leupeptin.  The lysate was cleared by centrifugation at 100,000 g for 
20 min at 4°C and the supernatant containing that MAP kinase activity was 
collected.  Phosphorylation assays were performed using 25 rnM Hepes, pH 
7.4,  10 mM MgCI2, 50/tM ATP[-l~-32P] (10 Ci/mmol), 1 mg/ml synthetic 
peptide, and 10/d of kinase preparation in a final volume of 25 p.l. Reactions 
were terminated after 20 rain at 22"C by the addition of 10/~1 of 95 % formic 
acid containing 75 mM ATE The phosphorylated synthetic peptide was iso- 
lated by applying 25/A of the reaction mixture onto phosphocellulose paper 
(P81; Whatman  Inc., Clifton, NJ) and washing the filters twice in 1 M acetic 
acid, 4 mM sodium pyrophosphate for 20 rain. Radioactivity  was quanti- 
tated by measuring Cerenkov radiation with a Beckman liquid scintillation 
counter (Beckman Instruments, Inc., Fullerton, CA). Nonspeeific incorpo- 
ration of radioactivity was determined in incubations without synthetic pep- 
tide substrate. 
Western Blot Analysis 
Cells were solubilized in lysis buffer (25 mM Hepes, pH 7.5, 5 mM EDTA, 
1 mM PMSF and 10/zg/ml leupeptin)  and the extracts were centrifuged  at 
100,000 g for 20 min at 4°C. The supernatant was subjected to SDS-PAGE 
and the resolved proteins were electrophoretically transferred onto a poly- 
vinylidene difluoride membrane (Immobilon-P; Millipore Corp., Bedford, 
MA). The membranes were then probed with a mouse anti-MAP/ERK ki- 
nase monoclonal antibody (Zymed Laboratories, Inc., San Francisco,  CA) 
to detect the MAP kinases.  The immune complexes  were visualized with 
Kodak X-O-MAT AR film (Eastman Kodak Co., Rochester, NY) using en- 
hanced chemiluminescence detection (Amersham International, Bucking- 
hamshire, England)  or tESI-goat anti-mouse Ig (Dupont-NEN).  Quantita- 
tive detection of the radioactivity  was performed using a Phosphorimager 
and ImageQuant  soft-ware (Molecular Dynamics Inc., Sunnyvale, CA). 
Stoichiometry of  EGF  Receptor Phosphorylation 
COS cells seeded in 35-ram dishes were labeled with [32p]phosphate by in- 
cubation with phosphate-free  modified Eagle's medium (Flow Laboratories, 
Inc., McLean, VA) supplemented with 0.1% calf serum (GIBCO-BRL) and 
2  mCi/ml [32P]phosphate (Dupont-NEN,  Boston, MA).  The cells were 
treated with 10% FBS for defined times. The cells were then lysed with 25 
mM Hepes, pH 7.4,  1% (vol/vol) Triton X-100, 1% (wt/vol) Na deoxycho- 
late, 0.1% Na dodecyisulphate,  50 mM Na fluoride, 5 mM EDTA, 10/~g/ml 
leupeptin, and 1 mM PMSE The EGF receptors were isolated by immu- 
noprecipitation using a rabbit polyclonal anti-EOF receptor antibody and 
subjected  to polyacrylamide  gel electropboresis.  The EGF receptor was 
then eluted from the gel and digested  with trypsin (8, 20).  The tryptic 
[3:p]phosphopeptides  obtained were resolved  by reverse-phase  high pres- 
sure liquid chromatography to isolate the peptide phosphorylated at Thr- 
669 (8, 20). The stoichiometry of phosphorylation  of the EGF receptor was 
determined as described previously  (8, 20). Calculation of the stoichiome- 
try of the phosphorylation of the EGF receptor requires knowledge of both 
the number  of EGF receptors and the specific radioactivity of the phosphate 
incorporated into the receptor.  EGF receptor number was estimated by 
Western blotting using  a  polyclonal  anti-receptor antibody using  t25I- 
protein A (Dupont-NEN) and detection with a Phospborimager (Molecular 
Dynamics Inc.). The Western blotting procedure was quantitated by com- 
parison with different amounts of plasma membranes electrophoresed on 
the same gel and transferred to nitrocellulose.  EGF receptor number in the 
plasma membranes was measured using a radioreceptor assay using 125I- 
EGF (8, 20). The specific radioactivity  of the "y-phosphate of ATP was mea- 
sured by the technique of England and Waish (23). 
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Transfected cells were plated into 4-well tissue culture chambers mounted 
on a glass slide (Lab-tek) and incubated for 10 h in DME supplemented with 
5% FIGS. TO examine the effect of serum on the cellular distribution  of MAP 
kinases, the cells were washed and incubated in serum-free DME for 18 h, 
and then treated without or with 10% FIBS (GIBCO-BRL) for 30 rain at 
37°C.  The cells were washed and processed for immunofluorescence  in 
KRH buffer (120 mM NaCI, 6 mM KCI,  1.2 mM MgCI2,  1 mM CaCl2, 
25 mM Hepes,  pH 7.4). 
The cells were fixed in KRH containing 3.7 % formaldehyde  (15 min, 
22°C),  washed and incubated in KRH containing 50 mM NIGCI for 15 
min at 22°C.  Then, they were permeabilized with 0.2% Triton X-100 in 
KRH (5 rain, 22°C), washed three times and incubated for I h in KRH con- 
taining the primary antibody and 20% horse serum at 22°C.  The primary 
antibodies and the dilutions used were: (a) a mouse monoclonal anti-c-Myc 
antibody (Ab-2; Oncogene Science, Inc., Manhassett, NY) diluted 1:20; (b) 
a mouse monoclonal anti-MAP/ERK kinase antibody (Zymed Laborato- 
ries, Inc.) diluted 1:500; and (c) a sheep polyclonal anti-EGF receptor anti- 
body diluted 1:200. The anti-EGF receptor antibody was purified from se- 
rum that was obtained after immunization of a  sheep with a bacterially 
expressed carboxyl-terminal fragment of the human EGF receptor as an an- 
tigen. 
After the incubation with primary antibodies, the cells were washed three 
times and incubated for 1 h at 22°C in KRH containing secondary antibod- 
ies and 20% horse serum. The secondary antibodies and the dilutions used 
were: (a) a rhudamine-conjngated rabbit anti-mouse Ig antibody (Boeh- 
finger Mannheim Corp.,  Indianapolis, IN) diluted  1:500;  (/7) an FITC- 
conjugated  goat anti-mouse Ig antibody (Kh'kegaard and Perry Laborato- 
ries, Inc., Galthersburg, MD) diluted 1:300; and (c) an FITC-conjngated 
rabbit anti-sheep lg antibody (ICN Immunochemicals, Costa Mesa, CA) 
diluted  1:500.  Actin filaments  were stained with 5  U/ml of rhodamine- 
labeled phallnidin  (Molecular Probes, Inc., Eugene, OR) during the incuba- 
tion with the secondary antibody.  The cells were then washed with KRH 
and mounted onto slides with a solution of 87.5% glycerol,  10% PBS, and 
2.5 % DABCO. Beads (200 nm) with a broad fluorescent emission (Molecu- 
lar Probes, Inc.) were added to the mounting medium as fiduciary markers. 
Control experiments were performed to assess the specificity of each an- 
tibody used for indirect immunofluorescence  experiments.  No fluorescence 
was detected using the secondary antibodies in the absence of primary anti- 
body. To confirm the presence of ruffling membranes after serum stimula- 
tion we stained the actin filaments in the cells with rhodamine-labeled phal- 
loidin. FITC-conjugated  WGA (Molecular Probes, Inc.) was also used to 
visualize the cell surfiw.e ruffling membrane. It was found that the expres- 
sion of both the wild-type and kinase-nngative  forms of the MAP kinases 
and p41  "~t had no significant effect on the ability of serum to in- 
duce the formation of the cell surface  membrane ruffles. 
Digital Imaging Microscopy and Image Restoration 
Cells are complex three-dimensional objects. The image from a single focal 
plane acquired using a conventional fluor-=,cence microscope is degraded 
by light originating above and below the plane of interest. Therefore, details 
that are contained within a two-dimensional image of  a cell may be obscured 
by the out of focus light. To minimize this problem, we used image restora- 
tion procedures to achieve increased contrast, higher resolution, and greater 
numerical accuracy (9, 24). 
Digital images of the fluorescence  distribution in single cells were ob- 
tained using a Nikon 60x Planapu objective (HA --- 1.4) on a Zeiss IM-35 
microscope equipped for epifluorescence  as previously described (24). Im- 
ages of various focal planes were obtained with a computer controlled focus 
mechanism and a thermoelectrically cooled charge coupled device camera 
(model 220; Photometrics Ltd., Tucson, AZ). The exposure of the sample 
to the excitation source was determined by a computer-controlled shutter 
and wavelength selector system (MVI, Avon, MA). The charge coupled de- 
vice camera and microscope fuuctious were controlled by a microcomputer, 
and  the data acquired  from the camera were ~  to  a  Silicon 
Graphics model 4D/GTX workstation (Mountainview,  CA) for image pro- 
cessing.  Images were corrected for non-uniformities in sensitivity and for 
the dark current of the charge coupled device detector. The calibration of 
the microscopy  blurring was  determined by measuring the instrument's 
point spread function as a series of optical sections at 0.125-t~m intervals 
of a 0.19-/an diameter fluorescently  labeled latex bead (Molecular Probes, 
Inc.). The image restoration algorithm used was based upon the theory of 
ill-posed problems and obtains quantitative dye density values within the 
cell that arc substantially more accurate than those in an unprocessed im- 
age (9). After image processing,  individual optical sections of cells were 
inspected and analyzed using computer graphics software  on a  Silicon 
Graphics workstation.  Quantitative molecular density values within a single 
optical section of individual cells were estimated by defining 15 concentric 
regions where the first region enclosed the cell nucleus and the fifteenth re- 
gion enclosed the outermost cell fluorescence  but excluded  extracellular 
background fluorescence.  The fluorescence  intensity values were normal- 
ized by calculating the ratio of the average-pixel intensity within each region 
to the average-pixel  intensity over all 15 regions. 
Laser Scanning Confocal Microscopy 
The confocal microscope, unlike standard fluorescent  microscopes, pro- 
vides an improved  resolution along the z  axis by rejecting out-of-focus 
fluorescence  (57). Thus, to identify the subcellular location of the p41  mar~ 
protein we used fluorophore-labeled  antibodies and a laser scanning confo- 
cal microscope (model MRC-600; Bio Rad Laboratories, Hercules, CA) 
equipped with a Nikun 60x oil immersion lens (HA -- 1.4). Image sets con- 
sisting of at least 20 optical sections at 0.3-1an intervals were obtained for 
analysis. Each pseudocolor image represents an optical section that was ac- 
quired by accumulating four scans of the laser. 
Results 
Biochemical Characterization of  p4~  and p41~ 
Two isoforms of the human ERK2 protein kinase that are ex- 
pressed  by HeLa cells have been identified by molecular 
cloning  (28). These protein kinases share a high degree of 
sequence identity with the exception that p41~ has a short 
NI-X2-terminal extension compared with ~  (Fig.  1). To 
determine  the  significance  of this  difference  in  primary 
structure, we examined the properties of the two ERK2 iso- 
forms expressed in cultured cells. Western blot analysis of 
the cell lysates detected a marked increase (*20-fold) in the 
level  of  expression  of  p40~  and  p41 "=o* (Fig.  2).  Im- 
munofluorescence  analysis demonstrated that the transfec- 
tion procedure resulted in the over-expression of MAP ki- 
nase in 15-20% of  the COS cells. Thus, we can calculate that 
the over-expression of MAP kinase in the transfected cells 
was ~100-fold over the endogenous MAP kinase. This over- 
expression  of p40-~  and p41~  was  associated  with  in- 
creased growth factor-stimulated MAP kinase activity  de- 
tected in cell lysates (Fig. 3). Significantly, the mutation of 
the ERK2 isoforms within the conserved protein kinase sub- 
domain  II  (Fig.  1)  resulted  in  the  expression  of kinase- 
negative forms of these MAP kinases  (Figs.  2 and 3). 
In  an  initial  analysis  of the  biochemical  properties  of 
and p41~  we compared the chromatographic elu- 
tion  profiles  of these  proteins  kinases.  A  similar  elution 
profile of p40  ~  and p41~  was observed  from an anion 
p41.=* 
p40 "~ 
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M~,JU~G.~Gp CM [ 
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Figure 1.  Comparison of the NH2-terminal region of p41  '~* and 
p40"~. The conserved protein kina~e sub-regions I and II (31) are 
illustrated. Regions of identity are presented and boxed. Point mu- 
tations in sub-region II that result in the loss of protein kinase activ- 
ity are presented below the protein sequence. 
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1041  "~  and  ~  in  cul- 
tured  cells.  Extracts  were 
prepared  from  COS-7  cells 
with  pCMV5 
(Control),  pCMV-p41  ~'a, 
pCMV-41  (AlaS4AlaSS)  ~, 
pCMV-p4(P~,  or  pCMV- 
p40(Ala42Ala43)  ~.  MAP ki- 
nase expression was examined 
by Western blot analysis  (50 
ttg  of the  cell  extract)  using a 
monoclonal anti-MAP kinase 
antibody  and  the  enhanced 
chemiluminescence detection procedure. Quantitation of the West- 
ern blot was performed using 125I-labeled protein A to detect the 
immune complexes and a Phosphorimager  with ImageQuant soft- 
ware (Molecular Dynamics Inc.). The level of over-expression of 
the transfeeted  MAP kinase was approximately  20-fold over the 
level of the endogenous MAP kinase. Similar data were obtained 
in three separate experiments. 
exchange column (Fig. 4). The partially purified protein ki- 
nases  were  then  applied  to  a  hydrophobic  interaction 
column.  This column was washed with high  salt and  the 
bound proteins were eluted using a decreasing salt gradient 
in the presence of ethylene glycol. A  single peak of protein 
kinase activity was eluted  from the  column in each case. 
However, the elution of ~  from the hydrophobic inter- 
action column was found to be modestly retarded in compar- 
ison to that of p41~  (Fig. 5). Together, these data demon- 
strate that  the  chromatographic  properties  of ~  and 
p41'~ are very similar. 
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Figure 3. Expression of p41  "~  and p40,m~ causes an increase in 
MAP kinase activity. Extracts were prepared from COS-'/cells that 
were mock-transfected (Control)  or transfected with plasmid vec- 
tors to express wild-type and kinase-negative forms of ~  and 
p41  "~. MAP kinase activity was measured using a synthetic pep- 
tide substrate based on the primary sequence of the EGF receptor 
surrounding  the  phosphorylation  site  Thr  ~.  The  results  are 
presented as the mean of  data obtained in three independent experi- 
ments. 
Figure 4. Anion exchange chromatography of IMI  "~t and p40  °~. 
10  100 mM dishes  of COS  cells  (&) expressing p41ym~ (e) or 
041~  (o) were treated with 100 nM EGF for 5 rain. Soluble ex- 
tracts were fractionated by analytical ion exchange chromatography 
using  a  Mono  Q  column  as  described  under  Materials  and 
Methods.  (A) Protein kinase activity in fractions eluted from the 
column  was  measured  using  the  synthetic  peptide  KRELVE- 
PLT~gPSGEAPNQALLR as substrate. The concentration of NaCI 
in the eluate is indicated (--). (B) Western blot analysis of MAP 
kinase elution from the Mono Q column. Fractions corresponding 
to the peak of protein kinase activity were analyzed by SDS-PAGE, 
transferred to Immobilon-P, and probed with MAP kinase antibody 
using enhanced chemiluminescence  detection. 
In  further  studies  to  compare the properties of p40"~ 
and  p41  "~,  we  examined the  effect of the  expression  of 
these kinases on a physiologically relevant target of the MAP 
kinase signal transduction pathway. In previous studies we 
have demonstrated that c-Myc is a substrate for phosphoryla- 
tion by MAP kinase at Ser-62 and that the phosphorylation 
at this site positively regulates the c-Myc transactivation do- 
main (51,  52).  We therefore examined the effect of the ex- 
pression of ~  and p41~  on the c-Myc transactivation 
The Journal of Cell Biology, Volume 122, 1993  1092 Figure 5. Phenyl-superose chromatography of 1>41~ and p400~. 
Peak fractions of MAP kinase activity obtained after anion ex- 
change chromatography (Fig. 4) were applied to a phenyl-Superose 
column. (,4) Protein kinase activity of ~  (*) arid I)41  mapk (O) 
was  measured using the synthetic peptide KRELVEPLTC~PSG - 
EAPNQALLR as a substrate. The protein  kinase activity  in the flow 
through (FT) and in the eluated fractions is presented. The concen- 
tration of NaCI in the eluate is indicated (---). (B) Fractions eorre- 
spending to the peak of protein kinase activity were analyzed by 
SDS-PAGE, transferred to Immobilon-P, and probed with MAP ki- 
nase antibody using enhanced chemiluminescence detection. 
domain by measurement of the expression of a  luciferase 
reporter gene.  Fig.  6  shows  that both ~  and p41 
caused a marked increase in transactivation of the reporter 
gene. In contrast, the kinase-negative forms of these MAP 
kinases did not significantly alter the reporter luciferase ac- 
tivity (Fig.  4).  Together, these data  demonstrate that the 
MAP kinase isoforms ~  and p41~  are biologically 
active when expressed in cultured cells. 
The results of the biochemical characterization of 
and p41"~ indicates that the properties of these protein ki- 
nases are similar (Figs. 2-6). This observation suggests that 
the function of  these protein kinases in vivo may also be simi- 
lar. However, this analysis does not take account of the im- 
portant role of sub-cellular compartmentation in determin- 
ing  enzyme function in vivo. We therefore compared the 
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Figure 6. Effect of p41~ and ~  on c-Myc-directed transac- 
tivation of reporter gene expression. The effect of transient expres- 
sion of wild-type and mutated (kinase-negative) forms of p41  '~'t 
and  p400~  was  investigated. COS-'/ cells  were  co-transfected 
with 0.02 #g of the activator plasmid pGAL4/Myc, 2 #g of the 
reporter plasmid pG5E1BLuc  and 1/~g of  a/3-galactosidase expres- 
sion vector (pCHll0) together with either 2 #g of pCMV5 (Con- 
trol), pCMV-p41~,  pCMV-p41(Ala~AIa55)  ~'t,  pCMV-p4(P~, 
or pCMV-p40(AIa42Ala43)  ~.  The cells were grown in medium 
containing 5 % FBS and extracts were prepared 48 h posttransfec- 
tion. Differences in transfection efficiency  were estimated by mea- 
surement of the/3-galactosidase activity (OD value) in 5 td cell ex- 
tract. Luciferase activities (light units) in 5/~1 of cell extract were 
measured and are presented as (Light Units/O.D.). Each data point 
represents the mean + S.E. of determinations obtained from three 
independent transfections. Similar data were obtained in three sep- 
arate experiments. 
cellular localization of p40"~,  p41~,  and substrates  for 
these protein kinases. 
Cellular Localization of  MAP kinase Substrates 
Several substrates for MAP kinase have been identified that 
are located in distinct subcellular compartments. The c-Myc 
protein is an example of a substrate that is found within the 
nucleus (3).  Immunofluorescence, digital imaging micros- 
copy, and image restoration procedures confirmed that the 
c-Myc protein was localized within the nucleus (Fig. 7). In 
contrast to the nuclear location of c-Myc, the EGF receptor 
is an example of a MAP kinase substrate that is present at 
the cell surface (16, 44, 53). Immunofluorescence analysis 
demonstrated that the EGF receptor was expressed at the cell 
surface with a  relatively uniform distribution (Fig. 7). 
In further experiments, the effect of serum treatment on 
the localization of these MAP kinase substrates was exam- 
ined. It was found that serum caused no significant alteration 
in the nuclear location of c-Myc (Fig. 7). However, serum 
caused a redistribution of the EGF receptor to the cell sur- 
face ruffling membranes which were visualized by staining 
cellular actin with rhodamine-labeled phalloidin (Fig.  7). 
Together, these data demonstrate that MAP kinase substrates 
are located within several cellular compartments in serum- 
treated  cells,  including  the  nucleus  and  the  cell  surface 
Gonzalez et al. Sub-cellular Distribution of  ~  and p41  "~  1093 Figure  7.  Localization  of 
MAP  kinase  substrate  pro- 
reins. Transfected COS-7 cells 
were serum-starved for  18 h 
and then treated without (A, 
C, and E) or with (B, D, and 
F) 10% FBS for 30 min. The 
cells were then fixed and ana- 
lyzed  by  indirect  immu- 
nofluorescence  using  a  dig- 
ital imaot~6ng microscope and 
image restoration techniques. 
Images  were  obtained  for 
c-Myc (A and B) and the EGF 
receptor (Cand D). Actin fila- 
ments  were  visualized  us- 
ing  rhodamine-conjugated 
phalloidin  (E  and  F).  The 
figure presents representative 
images of the fluorescence de- 
tected from single cells. 
/~gure 8.  Analysis of the dis- 
tribution of endogenous MAP 
kinase.  COS  cells  were 
treated with 10%  FBS for 30 
min. The cells were then fixed 
and analyrea by inahect ma- 
munofluorescence  using  a 
mouse monoclonal anti-MAP 
kinase  antibody  and  a  rho- 
damine-conjugated goat anti- 
mouse Ig antibody. The figure 
presents a  representative im- 
age  of  the  fluorescence  de- 
tected from  a  single cell by 
digital  imaging  microscopy 
and processed for image res- 
toration. 
The Journal of Cell Biology,  Volume 122, 1993  1094 ruffling membranes. To account for the observed phosphory- 
lation of these proteins in vivo, it is likely that MAP kinases 
are located within each of these cellular compartments. 
We examined the distribution of the endogenous MAP ki- 
nases present in COS cells by immunofluorescence. Fig.  8 
shows that the endogenous MAP kinases were detected at the 
cell surface, the perinuclear region, and within the nucleus 
of serum-treated cells. The cell surface and nuclear localiza- 
tion was observed within 5 rain of serum treatment and was 
sustained for at least 1 h (data not shown). This time course 
is similar to the rapid and sustained activation of MAP ki- 
nase caused by serum in these cells (Fig. 9). Consistent with 
the presence of activated MAP kinase at the cell surface, a 
marked increase in  EGF  receptor phosphorylation at the 
MAP  kinase  site  (Thr-669)  was  observed  in  serum- 
stimulated ceils (Fig. 9). 
Examination of MAP kinases present in COS cells demon- 
strates that these enzymes are present in several distinct sub- 
cellular compartments (Fig. 8). As this analysis does not dis- 
tinguish between different MAP kinase isoforms, the distri- 
bution observed represents an average of all of the isoforms 
detected. It is possible that the sub-cellular localization of 
different MAP kinase isoforms may be distinct. Therefore, 
we  examined the  sub-cellular  distribution  of p4(P~  and 
p41  rap* using an over-expression strategy to distinguish be- 
tween these individual MAP kinase isoforms and the endoge- 
nous MAP kinases present in COS cells (Figs.  10 and 11). 
Sub-cellular Localization of  p40-~ 
To investigate the localization of ~,  we performed im- 
munofluorescence analysis using a  monoclonal anti-MAP 
kinase antibody. The protein kinase p40"~ was visualized 
in the cytosol and the nuclear region of serum-starved cells 
(Fig.  10). Treatment of the ceils with serum was associated 
with a decreased level of p40-~ in the cytosol and an in- 
crease in the level of p40-~ in the nucleus (Fig.  10).  This 
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Figure 9. Comparison of the time course of MAP kinase activation 
and the phosphorylation of  the EGF receptor at Thr-669. COS cells 
were treated with 10% serum for defined times. The MAP kinase 
activity (o) and the stoichiometry of phosphorylation of the EGF 
receptor at Thr-669 (o) were measured. The figure presents the 
results (mean 5: SD) of three determinations. 
observation implies that serum treatment induces the trans- 
location of' p400~ from the cytosol into the nucleus. 
To achieve a quantitative understanding of the sub-cellular 
distribution of ~  we analyzed the fluorescence images 
obtained by digital  imaging  microscopy. The method we 
used allowed the compilation of data from several individual 
ceils and the calculation of the average fluorescence in dis- 
crete sub-cellular regions (Fig. 12). This quantitative analy- 
sis of the immunofluorescence demonstrated that the treat- 
ment of cells with serum caused a significant redistribution 
of  cytosolic  p40-~  to  the  nucleus  (Figs.  12  and  13). 
Significantly, no apparent localization of ~  to the sur- 
face ruffling membrane of serum-treated ceils was detected 
(Fig.  10). 
Sub-cellular Localization of  p41~p k 
The protein kinase p41"~ was detected in the cytosol of 
serum-starved cells (Fig.  11). A  low level of p41 "~p~ was 
also detected in the nuclear region (Fig. 11). Treatment of  the 
cells with serum caused a marked increase in the nuclear lo- 
calization of p41~  and a  corresponding decrease in the 
level of p41~  in the cytosol (Fig.  11). In addition, it was 
observed that p41"~ was localized at the border of serum- 
treated cells. This location at the cell border coincided with 
the cell surface ruffling membranes which were visualized 
by staining with rhodamine-labeled phalloidin and FITC- 
conjugated WGA (data not shown). The cell surface and nu- 
clear localization of p41~  observed using the digital im- 
aging microscope and image restoration procedures (Fig. 11) 
was also observed by analysis of the immunofluorescence by 
laser scanning confocal microscopy (Fig.  14).  Quantitative 
analysis of the immunofluorescence demonstrated that se- 
rum caused a significant redistribution of p41~  to the nu- 
clear region and to the cell surface ruffling membrane (Figs. 
12 and  13). 
MAP Kinase Activity Is Required for 
Redistribution to the Cell Surface, but not for 
Translocation to the Nucleus 
The  MAP  kinase  isoforms p4(P~  and  p41'~  were  ob- 
served to redistribute from the cytosol to the nucleus after 
treatment of cells with  serum (Figs.  10-13).  The kinase- 
negative mutant forms of p40-~ and p41 m~ also exhibited 
serum-stimulated  translocation  into  the  nucleus  (Figs. 
10-13). Thus, kinase activity is not required for the serum- 
induced nuclear translocation of p40-~ and p41~p  k. In con- 
trast, kinase activity was required for the serum-stimulated 
redistribution of MAP kinase to the cell surface ruffling 
membrane. Furthermore, the cell surface redistribution was 
found only for p41'~  k and  was  not  observed for 
(Figs.  10 and 11). Together, these observations demonstrate 
that there are distinct structural requirements for the serum- 
stimulated redistribution of MAP kinases to different cellu- 
lar compartments. 
Discussion 
There has been much interest in the role of MAP kinases in 
signal transduction because these enzymes appear to inte- 
grate signaling pathways that are initiated by many types of 
cell surface receptors (2, 15, 17, 19, 46). Molecular cloning 
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ERK2 isoform ~.  Cells 
expressing  wild-type  (,4 and 
B)  and  kinase-negative  mu- 
tant  (C  and  D)  forms  of 
were  serum  starved 
for 18 h and then treated with- 
out (,4 and C) or with (B and 
D) 10% FBS for 30 rain.  The 
ceils were fixed and analyzed 
by  indirect  immunofluores- 
cence using a  mouse mono- 
cloned anti-MAP kinase anti- 
body and an FITC-conjugated 
goat anti-mouse Ig antibody. 
All images were obtained by 
digital  imaging  microscopy 
and  processed  for  image 
restoration.  The  figure  pre- 
sents representative  images of 
the fluorescence detected from 
single  cells. 
Figure 11. Localization of the 
ERK2 isoform IMI~.  Cells 
expressing  wild-type  (A  and 
B ) and kinase-negative  (C and 
D)  forms  of  p41~.  The 
cells were serum-starved for 
18 h and then treated without 
(A and C) or with (B and D) 
10%  FBS  for  30  rain.  The 
cells  were  then  fixed  and 
analyzed  by  indirect  immu- 
nofluorescence  microscopy 
using  a  mouse  monoclonal 
anti-MAP  kinase  antibody 
and an FITC-conjugated goat 
anti-mouse  Ig  antibody.  All 
images were obtained by digi- 
tal  imaging microscopy.  The 
figure presents  representative 
images of the fluorescence de- 
tected from single cells. 
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exhibit heterogeneous expression in human tissues (6, 7, 28). 
These isoforms have similar in vitro substrate specificity (3, 
14, 19, 27) and may have similar functions in vivo. However, 
as MAP kinase substrates are located within several cellular 
compartments, it is possible that these MAP kinase isoforms 
may have distinct roles during signal transduction because of 
differences in sub-cellular localization. 
We have previously described two isoforms of the human 
ERK2 protein kinase that are expressed in HeLa cells. These 
isoforms were designated ~  and 1)41~ according to 
their predicted molecular mass  (28).  Analysis of the  se- 
quence of these protein kinases indicates that they share a 
high degree of sequence identity except that p41~  has a 
short  NH2-terminal  Ala-rich  extension  that  is  absent  in 
(Fig.  1).  To examine the significance of this differ- 
ence  in structure,  we compared the properties  of 
and p41-*o~.  It  was  found that these  protein  kinases  ex- 
hibited similar chromatographic properties (Figs. 4 and 5) 
and that both kinases were able to transduce a signal to the 
nucleus  (Fig.  6).  Thds,  the  biochemical  properties  of 
and p41"~ are  very similar.  However,  in  further 
studies using immunofluorescence and digital imaging mi- 
croscopy, it was found that these MAP kinase isoforms differ 
in their sub-cellular localization. This observation suggests 
that these MAP kinase isoforms may couple to distinct signal 
transduction targets in addition to common pathways. 
Serum-induced Redistribution of  MAP Kinase to 
the Nucleus 
The nucleus has been demonstrated to be a  target of the 
MAP kinase signal transduction pathway (52). Physiological 
functions of MAP kinases in the nucleus are likely to include 
the regulation of gene expression (19). For example, c-Myc, 
NF-IL6, c-Jun, TALl and p62TCF/Elk-1 have been demon- 
strated to be phosphorylated by MAP kinases (1, 3,  11, 13, 
25, 30, 39, 42, 48, 51, 52). In serum-starved cells only a very 
low level of MAP kinase is detected in the nucleus. However, 
treatment of cells with serum causes the redistribution of 
MAP kinase from the cytosol to the nucleus (3, 10, 49, 52). 
Previous investigations of the cellular distribution of MAP 
kinases have been performed without reference to the analy- 
sis of individual isoforms (3, 10, 49). Here we show that se- 
rum  treatment caused  the  redistribution of tWO  different 
MAP kinase isoforms (p40-~ and p41"~) from the cytosol 
to the nucleus (Figs. 10 and 11). This serum-stimulated nu- 
clear translocation was also observed for the kinase-negative 
forms of ~  and p41"~ (Figs.  10 and  11). Together, 
these data demonstrate that serum causes the nuclear redis- 
tribution of both ~  and p41~ and that intrinsic MAP 
kinase activity is not required for the nuclear accumulation. 
The mechanism of serum-induced translocation of MAP 
kinases remains unknown because a nuclear localization se- 
quence within the primary structure of p400~ and p41"~ 
has not been identified (28). However, three general mecha- 
nisms can be proposed: (a) MAP kinase may enter the nu- 
cleus because of a general increase in nuclear transport in 
serum-treated cells. We are, however, unaware of any prece- 
dent for this form of regulation of nuclear localization. (b) 
It is possible that MAP kinases may have a cryptic nuclear 
localization sequence that is exposed by the treatment of  cells 
with serum. Kinase-negative mutant forms of p40  °~ and 
p41~*~ are translocated into the nucleus (Figs.  10 and 11). 
Thus, intrinsic kinase activation is not required for translo- 
cation. However, it is possible that the mechanisms of MAP 
kinase activation (Thr and Tyr phosphorylation) may act as 
a signal for translocation. (c) If MAP kinase lacks a func- 
tional nuclear localization sequence, it is possible that this 
signal may be provided by association with another protein. 
Proteins that could account for this activity have not been 
identified, but one candidate is represented by MAP kinase 
kinase (5,  18, 33, 50, 56, 59). 
Serum-induced Redistribution of  MAP kinase to the 
Cell Surface RujOtin$  Membrane 
The formation of cell surface membrane ruffles is a common 
event that is observed after the treatment of  cells with growth 
factors. Recent studies have established an important role for 
small GTP-binding proteins (rho and rac) in the formation 
of the  membrane  ruffles  and  the  reorganization  of the 
cytoskeleton (10, 49).  It is possible that the localization of 
MAP kinase in the membrane ruffles may be related to the 
regulation of the cytoskeleton in this region of the cell (12, 
22, 29).  Alternatively, the serum-stimulated redistribution 
of MAP kinase to the membrane ruffles may function to cou- 
ple the MAP ldnase signal transduction pathway to targets 
located at the cell surface. Examples of potential targets of 
MAP kinase at the cell surface (19) include the EGF receptor 
(16, 44, 53) and phospholipase A2 (37, 43). 
Analysis of the  cellular distribution of p41~  demon- 
strated that this protein kinase is localized at the cell surface 
ruffling membrane after serum-stimulation (Fig. 11). How- 
ever,  the cell surface translocation of ~  was not ob- 
served (Fig.  10).  This observation suggests that the NH2- 
terminal region of p41~  is required for localization at the 
cell surface (Figs.  10 and 11). Thus, it is possible that the 
12-amino acid NH2-terminal extension could act as a "sig- 
nal sequence" for cell surface membrane localization. How- 
ever,  strong evidence against this hypothesis was obtained 
from the analysis of the kinase-negative MAP kinases which 
did not localize to the cell surface ruffling membranes after 
serum  treatment.  This  observation demonstrates that the 
12-amino  acid NH2-terminal extension found in the pri- 
mary sequence of p41~  is not sufficient to confer serum- 
dependent localization at the cell surface. Together,  these 
data indicate that the cell surface localization of IM1  ~'~ in 
serum-stimulated cells requires both protein kinase activa- 
tion and the NH2-terminal region of p41~. Further studies 
are required to identify structures within the cell surface 
ruffling membrane that are required for the cell surface lo- 
calization of p41"~. 
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Figure  13.  Comparison  of 
MAP  kinase  distribution  in 
control  and  serum-treated 
cells.  The  relative molecular 
density of MAP kinase in the 
nuclens (A) and at the cell sur- 
face  rufliing  membrane  (B) 
is  presented  (mean  +  SD, 
n  =  8). The density of MAP 
kinase was normalized by di- 
viding  the  average  pixel  in- 
tensity (Fig.  10) of region 15 
(nucleus)  and  region  1  (cell 
surface rufliing membrane) by 
the average pixel  intensity of 
region 12 (a cytosolic serum- 
independent region). 
Figure 14. Analysis of the sub-cellular distribution of p41~  by confocal microscopy. Three different focal planes are shown of a cell in- 
cubated with 10%  FBS for 30 min. The images shown are representative of cells observed in three separate experiments.  The intensity 
of the fluorescence in each image is shown in pseudocolors and the pixel intensity across the references line (green) is illustrated. Bar, 30/~m. 
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